Ajanta Pharmaceuticals share price
You have to be logged in to add this to Watchlist.Ajanta Pharmaceuticals is trading 1.40% upper at Rs 3,001.80 as compared to its last closing price. Ajanta Pharmaceuticals has been trading in the price range of 3,099.85 & 2,964.00. Ajanta Pharmaceuticals has given 42.06% in this year & 4.78% in the last 5 days.
Ajanta Pharmaceuticals has TTM P/E ratio 46.01 as compared to the sector P/E of 33.29.There are 10 analysts who have initiated coverage on Ajanta Pharmaceuticals. There are 2 analysts who have given it a strong buy rating & 4 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.
The company posted a net profit of 216.48 Crores in its last quarter.
Listed peers of Ajanta Pharmaceuticals include IPCA Laboratories (0.97%), Biocon (1.55%), Ajanta Pharmaceuticals (1.40%) etc.
Ajanta Pharmaceuticals has a 33.74% public holding.The Mutual Fund holding in Ajanta Pharmaceuticals was at 14.93% in 30 Sep 2024. The MF holding has increased from the last quarter. The FII holding in Ajanta Pharmaceuticals was at 9.11% in 30 Sep 2024. The FII holding has increased from the last quarter.
Ajanta Pharmaceuticals share price range
|
| ||||
|
| ||||
Ajanta Pharmaceuticals share Key Metrics
| Market Cap ( ₹ Cr.) | 36,974.61 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Ajanta Pharmaceuticals Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 28-Oct-24 | Quarterly Results |
| 30-Jul-24 | Quarterly Results |
| 02-May-24 | Audited Results & Buy Back of Shares |
| 31-Jan-24 | Quarterly Results & 2nd Interim Dividend |
| 31-Oct-23 | Quarterly Results |
| 27-Jul-23 | Quarterly Results |
| 05-May-23 | Audited Results |
| 10-Mar-23 | Buy Back of shares |
| 01-Feb-23 | Quarterly Results |
| 03-Nov-22 | Quarterly Results & Interim Dividend |
| Meeting Date | Announcement On | Purpose |
| 18-Jul-24 | 14-Jun-24 | AGM |
| 30-May-24 | 02-May-24 | Others |
| 18-Jul-23 | 05-May-23 | AGM |
| 11-Mar-23 | 07-Feb-23 | POM |
| 04-Aug-22 | 21-Jun-22 | AGM |
| 14-Jul-21 | 03-Jun-21 | AGM |
| - | 28-Dec-21 | Others |
| - | 10-Mar-23 | Others |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 25-Oct-24 | 06-Nov-24 | 06-Nov-24 | 28 |
| 25-Jan-24 | 08-Feb-24 | 08-Feb-24 | 26 |
| 24-Jul-23 | 04-Aug-23 | 04-Aug-23 | 15 |
| 25-Jul-23 | 04-Aug-23 | 04-Aug-23 | 10 |
| 02-Nov-22 | 14-Nov-22 | 11-Nov-22 | 7 |
| 21-Oct-21 | 10-Nov-21 | 09-Nov-21 | 9.5 |
| Announcement Date | Record Date | Ex-Bonus | Description |
| 10-May-22 | 23-Jun-22 | 22-Jun-22 | Bonus issue in the ratio of 1:2 of Rs. 2/-. |
FAQs about Ajanta Pharmaceuticals share price
Ajanta Pharmaceuticals is trading at 3001.80 as on Mon Nov 25 2024 10:26:58. This is 1.40% upper as compared to its previous closing price of 2960.30.
The market capitalization of Ajanta Pharmaceuticals is 36974.61 Cr as on Mon Nov 25 2024 10:26:58.
The average broker rating on Ajanta Pharmaceuticals is Hold. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 4 analysts have given a buy rating
- 1 analysts have given a hold rating
- 1 analysts have given a sell rating
- 2 analysts have given a strong sell rating
The 52 wk high for Ajanta Pharmaceuticals is 3485.75 whereas the 52 wk low is 1852.55
Ajanta Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 46.01
- Sector P/E: 33.29
- Dividend Yield: 0.95%
- D/E ratio: 0.01
Ajanta Pharmaceuticals reported a net profit of 816.17 Cr in 2024.
Ajanta Pharmaceuticals Quick Links
Ajanta Pharmaceuticals Dividend Ajanta Pharmaceuticals Bonus Ajanta Pharmaceuticals News Ajanta Pharmaceuticals AGM Ajanta Pharmaceuticals Rights Ajanta Pharmaceuticals Splits Ajanta Pharmaceuticals Board Meetings Ajanta Pharmaceuticals Key Metrics Ajanta Pharmaceuticals Shareholdings Ajanta Pharmaceuticals Profit Loss Ajanta Pharmaceuticals Balance Sheet Ajanta Pharmaceuticals Cashflow Ajanta Pharmaceuticals Q1 Results Ajanta Pharmaceuticals Q2 Results Ajanta Pharmaceuticals Q3 Results Ajanta Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks